Korea pharma groups warn price reform will cut 3.6 trillion won and cost jobs

Chosun Biz

22 December 2025 - Pharma associations form emergency committee to demand delay and joint review of planned generic price cuts.

Tensions are rising between the government and the pharmaceutical-bio industry over how to calculate the prices of generics—copycat drugs developed with the same ingredients and dosages as new drugs whose patents have expired.

Read Chosun Biz article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Korea